Article ID Journal Published Year Pages File Type
3851444 American Journal of Kidney Diseases 2009 10 Pages PDF
Abstract
Overall, a multistep treatment strategy consisting of pravastatin, vitamin E, and B vitamins had no effect on plasma ADMA levels in a stage 2 to 4 CKD population. This suggests that the beneficial effects of the intervention were not mediated by changes in ADMA levels. Possible ADMA-lowering effects of vitamin E deserve further attention.
Related Topics
Health Sciences Medicine and Dentistry Nephrology
Authors
, , , , , , , , , , , , , , , , , ,